{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/tempus-ai-tem/",
 "dataUrl": "https://clearank.com/stock/tempus-ai-tem/data.json",
 "title": "Tempus AI (TEM) Stock Forecast & Price Target (2026)",
 "description": "Tempus AI Inc (TEM) stock: Healthcare, Health Information Services. $12.4B market cap. AI rating, technicals, 2030 forecast and trade plans.",
 "headline": "Tempus AI Inc (TEM)",
 "published": "2026-07-01T09:38:46+00:00",
 "modified": "2026-09-16T06:45:52.757+00:00",
 "generated": "2026-09-16T10:08:42.725Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by the CleaRank editorial team; prices delayed up to 15 minutes.",
 "asset": {
  "ticker": "TEM",
  "name": "Tempus AI Inc",
  "type": "Common Stock",
  "exchange": "NASDAQ",
  "currency": "USD",
  "sector": "Healthcare",
  "industry": "Health Information Services",
  "country": "United States",
  "website": "https://www.tempus.com"
 },
 "quote": {
  "price": 68.85,
  "previousClose": 62.21,
  "change": 6.64,
  "changePercent": 10.67,
  "open": 61.905,
  "high": 68.939,
  "low": 61.88,
  "volume": 8227400,
  "averageVolume": 5546400,
  "marketCap": 12422932950,
  "fiftyTwoWeekHigh": 104.32,
  "fiftyTwoWeekLow": 40.77,
  "marketOpen": false,
  "asOf": "2026-09-16T06:45:52.000Z"
 },
 "statistics": {
  "pe": -47.81,
  "eps": -1.44,
  "dividendYield": 0,
  "beta": 3.724,
  "priceToSales": 7.435275,
  "priceToBook": 23.88102,
  "revenueTtm": 1432018944,
  "grossMargin": 0.6444628038673311,
  "returnOnEquity": -0.67442
 },
 "technicals": {
  "rsi": 50.2,
  "macd": 2.12,
  "sma50": 56.08,
  "sma200": 56.16,
  "rsiSignal": "Neutral",
  "trend": "Neutral",
  "pricePosition": "Bullish",
  "macdSignal": "Bullish",
  "rating": "Bullish"
 },
 "analysis": {
  "rating": "Hold",
  "score": 59,
  "consensus": "Hold",
  "fairValue": 70,
  "analystTarget": 70,
  "analystCount": 19,
  "wallStreetConsensus": "Hold",
  "generatedAt": "2026-09-16T06:45:52.000Z",
  "priceAtAnalysis": 68.85,
  "volatility": {
   "daily": 6.74,
   "risk": "volatile"
  }
 },
 "tradePlan": {
  "bias": "Neutral",
  "conservativeEntry": 68.16,
  "aggressiveEntry": 68.85,
  "stopLoss": 56.5,
  "stopLossPercent": 17.11,
  "targets": [
   70.21,
   71.57,
   73.61
  ]
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 40.45,
    "base": 76.78,
    "upside90th": 145.73
   },
   {
    "year": 2028,
    "downside10th": 34.6,
    "base": 85.63,
    "upside90th": 211.93
   },
   {
    "year": 2029,
    "downside10th": 31.47,
    "base": 95.5,
    "upside90th": 289.74
   },
   {
    "year": 2030,
    "downside10th": 29.56,
    "base": 106.5,
    "upside90th": 383.65
   },
   {
    "year": 2031,
    "downside10th": 28.34,
    "base": 118.77,
    "upside90th": 497.72
   },
   {
    "year": 2032,
    "downside10th": 27.57,
    "base": 132.45,
    "upside90th": 636.41
   },
   {
    "year": 2033,
    "downside10th": 27.11,
    "base": 147.71,
    "upside90th": 804.86
   },
   {
    "year": 2034,
    "downside10th": 26.89,
    "base": 164.73,
    "upside90th": 1009.06
   },
   {
    "year": 2035,
    "downside10th": 26.87,
    "base": 183.71,
    "upside90th": 1256.09
   },
   {
    "year": 2036,
    "downside10th": 27.01,
    "base": 204.88,
    "upside90th": 1554.33
   }
  ]
 },
 "faqCount": 7,
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "price",
   "title": "TEM Price Analysis"
  },
  {
   "id": "market-metrics",
   "title": "Market Metrics",
   "facts": {
    "Open": "$61.91",
    "Day Range": "$61.88 to $68.94",
    "Prev Close": "$62.21",
    "Volume": "8.23M",
    "52-Week Range": "$40.77 to $104.32",
    "Market Cap": "$12.42B"
   }
  },
  {
   "id": "peer-benchmarking",
   "title": "Peer Benchmarking",
   "text": [
    "Sector Position Analysis Trading at a significant premium to sector peers (+23%), suggesting market expectations for superior growth or market position."
   ]
  },
  {
   "id": "financials",
   "title": "TEM Financial Performance",
   "text": [
    "Analysis: In the last 3 quarters, TEM beat estimates 3 times. However, the stock fell 3 times the next day. This suggests positive news is often \"priced in\" or investors are selling the news."
   ]
  },
  {
   "id": "analysis",
   "title": "TEM Analysis",
   "text": [
    "Tempus AI Inc (TEM) is trading above its 50-day and 200-day moving averages ($56.08 and $56.16), currently at $56.08 and $56.16 respectively, suggesting an overall bullish trend. The stock is also above its 20-day Exponential Moving Average at $61.90. The Relative Strength Index (RSI) is at 50.2, indicating neutral momentum, while the Stochastic Oscillator at 78.55 suggests it is approaching overbought territory. Volume has been notably active, with the latest volume at 8.23 million, approximately 48.3% above the average of 5.55 million, indicating strong investor interest. Key support levels are near the 50-day SMA, while resistance may be found near recent highs. The current technical setup suggests a neutral to slightly bullish short-term outlook, but the significant insider selling could weigh on price action.",
    "Insiders have sold over $320.4 million worth of stock across 138 transactions, resulting in a 'Heavy Sell Signal' and indicating potential concerns about valuation or future prospects.",
    "The company continues to demonstrate strong revenue growth, projected at 26.00% for the current year, and has consistently beaten analyst EPS loss estimates, suggesting operational improvements.",
    "With 19 analysts covering the stock, the median price target is $70, suggesting a modest 1.7% upside from the current price, reflecting a balanced view on the stock's near-term potential.",
    "Tempus AI Inc (TEM) is expected to continue its strong revenue growth trajectory, with current year estimates projecting a 26.00% increase to $1.6 billion and next year's estimates at $2 billion, representing 23.00% growth. The company's ability to beat EPS loss estimates suggests operational improvements, and the median analyst price target of $70 indicates a slight upside from the current price. However, the outlook is tempered by significant insider selling and a premium valuation. A key risk is whether the company can achieve profitability to justify its current market capitalization. Positive developments in achieving net income or significant new contract wins could drive the stock higher, while continued insider divestitures or a slowdown in revenue growth could pressure the stock downwards."
   ],
   "lists": {
    "ProTips": [
     "Monitor insider transaction activity closely, as the current 'Heavy Sell Signal' with over $320 million in dispositions warrants caution.",
     "Given the high Price-to-Sales ratio of 7.44, investors should focus on the company's ability to achieve profitability and sustain its high revenue growth rate.",
     "Consider the potential impact of the company's negative profit margins and high debt-to-equity ratio on its long-term financial health."
    ]
   },
   "catalysts": [
    {
     "type": "Bearish",
     "title": "Significant Insider Selling Pressure",
     "text": "Insiders have sold over $320.4 million worth of stock across 138 transactions, resulting in a 'Heavy Sell Signal' and indicating potential concerns about valuation or future prospects.",
     "source": "Insider Trading Data"
    },
    {
     "type": "Bullish",
     "title": "Strong Revenue Growth and Positive EPS Surprises",
     "text": "The company continues to demonstrate strong revenue growth, projected at 26.00% for the current year, and has consistently beaten analyst EPS loss estimates, suggesting operational improvements.",
     "source": "Wall Street Estimates"
    },
    {
     "type": "Neutral",
     "title": "Analyst Coverage and Price Targets",
     "text": "With 19 analysts covering the stock, the median price target is $70, suggesting a modest 1.7% upside from the current price, reflecting a balanced view on the stock's near-term potential.",
     "source": "Wall Street Consensus"
    }
   ]
  },
  {
   "id": "key-statistics",
   "title": "Key Statistics",
   "text": [
    "Tempus AI Inc (TEM) exhibits a Price-to-Sales ratio of 7.44, considerably higher than the sector median of 3.70, indicating that investors are paying a premium for its revenue. The company's Profit Margin is negative at -17.77%, and its Return on Equity is a weak -67.44%, reflecting ongoing losses. The Debt-to-Equity ratio stands at 3.25, which is higher than the sector median of 3.25, suggesting a leveraged balance sheet. While the company is not currently profitable, its revenue growth of 21.6% is strong, and forward estimates project significant sales expansion. The current valuation appears stretched given the lack of profitability and high P/S ratio, but this may be justified by the company's growth trajectory in the health information services sector. Investors should monitor the path to profitability closely.",
    "Tempus AI Inc (TEM) has shown a pattern of beating EPS estimates in recent quarters, though the estimates themselves are for losses. In the quarter ending June 2026, the company reported an EPS of -0.04 against an estimate of -0.15, a positive surprise of 73.33%, though the stock price declined by 0.95%. Prior quarters also showed positive surprises in EPS, with the stock reacting negatively in two of the three reported quarters. Revenue growth remains strong, with current quarter estimates showing a 23.00% year-over-year increase. The company's ability to consistently beat loss estimates suggests operational efficiency improvements, but the path to net profitability remains a key focus for investors.",
    "The most significant risk for Tempus AI Inc (TEM) is the heavy insider selling, with over $320 million in dispositions, signaling potential concerns from management regarding future performance or valuation. The company's valuation is also a risk, as its Price-to-Sales ratio of 7.44 is substantially higher than the sector median, indicating it trades at a premium. Also, Tempus AI Inc is not currently profitable, with negative profit margins and return on equity, which could pose challenges if revenue growth falters."
   ],
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "Market Cap",
       "cells": [
        "12.42B"
       ]
      },
      {
       "label": "P/E Ratio",
       "cells": [
        "N/A (Negative EPS)"
       ]
      },
      {
       "label": "EPS (TTM)",
       "cells": [
        "-1.44"
       ]
      },
      {
       "label": "Dividend Yield",
       "cells": [
        "0.00%"
       ]
      },
      {
       "label": "52 Week High",
       "cells": [
        "104.32"
       ]
      },
      {
       "label": "52 Week Low",
       "cells": [
        "40.77"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "technical-indicators",
   "title": "Technical Indicators",
   "text": [
    "Technical Rating Bullish RSI Neutral SMA Cross Neutral Price vs SMA Bullish MACD Bullish Price action is firmly bullish above key moving averages."
   ],
   "facts": {
    "RSI": "Neutral",
    "SMA Cross": "Neutral",
    "Price vs SMA": "Bullish",
    "MACD": "Bullish"
   },
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "RSI (14)",
       "cells": [
        "50.20"
       ]
      },
      {
       "label": "MACD",
       "cells": [
        "2.12"
       ]
      },
      {
       "label": "SMA 50",
       "cells": [
        "56.08"
       ]
      },
      {
       "label": "SMA 200",
       "cells": [
        "56.16"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "correlations",
   "title": "Market Correlations",
   "text": [
    "How this stock moves relative to other assets",
    "Based on 1 year of daily price data. Correlations may vary over different time periods."
   ],
   "facts": {
    "Correlation with S&P 500 (SPY)": "+0.47",
    "Correlation with Nasdaq 100 (QQQ)": "+0.45",
    "Correlation with Bitcoin (BTC)": "+0.33",
    "Correlation with Gold (XAU)": "+0.14"
   }
  },
  {
   "id": "trade-plans",
   "title": "TEM Trade Plans",
   "text": [
    "Specific entry, exit, and risk management levels",
    "Enter now if confident",
    "Volatility-Adjusted Stop Loss Calculated based on RSI (50.2) and current market volatility",
    "Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3"
   ],
   "facts": {
    "TARGET 1": "$70.21",
    "TARGET 2": "$71.57",
    "TARGET 3": "$73.61",
    "STOP LOSS": "$56.50"
   }
  },
  {
   "id": "seasonality",
   "title": "Seasonal Patterns",
   "text": [
    "Historical monthly performance trends",
    "Limited data: Based on ~2 years of trading history. Patterns may not be statistically significant."
   ],
   "facts": {
    "Average Jan return": "+31.74%",
    "Average Feb return": "-8.88%",
    "Average Mar return": "-10.23%",
    "Average Apr return": "+13.70%",
    "Average May return": "-0.91%",
    "Average Jun return": "-1.07%",
    "Average Jul return": "-1.26%",
    "Average Aug return": "+40.79%",
    "Average Sep return": "+5.84%",
    "Average Oct return": "-6.90%",
    "Average Nov return": "+11.87%",
    "Average Dec return": "-33.32%"
   }
  },
  {
   "id": "risk",
   "title": "Risk & Volatility",
   "facts": {
    "Daily Volatility": "6.74%"
   },
   "lists": {
    "Risk considerations": [
     "Monitor position sizing based on current volatility levels",
     "Consider stop-loss placement beyond recent price range",
     "Diversification helps mitigate single-stock risk exposure"
    ]
   }
  },
  {
   "id": "growth",
   "title": "Growth of $10,000",
   "text": [
    "A $10,000 investment in TEM in June 2024 would be worth about $17,106 today, compared with about $13,954 for the same investment in the S&P 500 benchmark."
   ]
  },
  {
   "id": "monte-carlo",
   "title": "Monte Carlo Projection (10yr)",
   "text": [
    "CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in TEM today could grow to about $29,757 by 2036 in the base case, with a bull case near $225,755 and a bear case around $3,922. Projections are statistical simulations, not guarantees."
   ]
  },
  {
   "id": "price-prediction",
   "title": "TEM Stock Price Prediction: 2030",
   "text": [
    "CleaRank's simulation projects a price near $106 for TEM by 2030 in the base case, from $68.85 today (1.5x over 4 years). The downside path ends near $29.56. These are outcomes of a Monte Carlo simulation run on TEM's historical return distribution, not price targets, and they assume no dividends are reinvested.",
    "Method: 10,000 simulated price paths using TEM's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. TEM is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice."
   ],
   "tables": [
    {
     "caption": "TEM simulated price paths by year",
     "columns": [
      "Year",
      "Downside (10th pct)",
      "Base case",
      "Upside (90th pct)"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$40.45",
        "$76.78",
        "$146"
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$34.60",
        "$85.63",
        "$212"
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$31.47",
        "$95.50",
        "$290"
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$29.56",
        "$106",
        "$384"
       ]
      },
      {
       "label": "2031",
       "cells": [
        "$28.34",
        "$119",
        "$498"
       ]
      },
      {
       "label": "2032",
       "cells": [
        "$27.57",
        "$132",
        "$636"
       ]
      },
      {
       "label": "2033",
       "cells": [
        "$27.11",
        "$148",
        "$805"
       ]
      },
      {
       "label": "2034",
       "cells": [
        "$26.89",
        "$165",
        "$1,009"
       ]
      },
      {
       "label": "2035",
       "cells": [
        "$26.87",
        "$184",
        "$1,256"
       ]
      },
      {
       "label": "2036",
       "cells": [
        "$27.01",
        "$205",
        "$1,554"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "people-also-watch",
   "title": "People Also Watch",
   "links": [
    {
     "text": "RMD ResMed Inc. NYSE $229.44 +2.89%",
     "url": "https://clearank.com/stock/rmd-stock-analysis/"
    },
    {
     "text": "CRNX Crinetics Pharmaceuticals, Inc. NASDAQ $84.95 +0.00%",
     "url": "https://clearank.com/stock/crinetics-pharmaceuticals-crnx/"
    },
    {
     "text": "CNC Centene Corp. NYSE $67.66 -2.52%",
     "url": "https://clearank.com/stock/centene-cnc/"
    },
    {
     "text": "ILMN Illumina Inc. NASDAQ $222.36 +6.80%",
     "url": "https://clearank.com/stock/ilmn-stock-analysis/"
    },
    {
     "text": "RXRX Recursion Pharmaceuticals, Inc. NASDAQ $3.24 -4.99%",
     "url": "https://clearank.com/stock/rxrx-stock-analysis/"
    },
    {
     "text": "MDT Medtronic NYSE $93.75 -0.05%",
     "url": "https://clearank.com/stock/medtronic-mdt/"
    },
    {
     "text": "MRK Merck & Co., Inc. NYSE $143.17 -1.16%",
     "url": "https://clearank.com/stock/merck-mrk/"
    },
    {
     "text": "QDEL QuidelOrtho Corporation NASDAQ $11.12 -5.60%",
     "url": "https://clearank.com/stock/quidelortho-qdel/"
    }
   ]
  },
  {
   "id": "related-comparisons",
   "title": "Popular Comparisons",
   "links": [
    {
     "text": "UEC vs CCJ Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/uec-vs-ccj/"
    },
    {
     "text": "SCHD vs JEPI Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/schd-vs-jepi/"
    },
    {
     "text": "ENPH vs FSLR Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/enph-vs-fslr/"
    }
   ]
  },
  {
   "id": "insider-trading",
   "title": "TEM Insider Trading Analysis",
   "facts": {
    "Bought": "None",
    "Sold": "$320.4M",
    "Insiders": "16",
    "Avg Transaction": "$2.9M"
   },
   "tables": [
    {
     "caption": "Recent insider transactions in TEM",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "Feb 27, 2025",
       "cells": [
        "LEFKOFSKY ERIC P Chief Executive Officer",
        "Sell",
        "3.2M",
        "$190.4M"
       ]
      },
      {
       "label": "Dec 11, 2024",
       "cells": [
        "RED SKY VENTURES L L C Beneficial Owner of more than 10% of a Class of Security",
        "Sell",
        "2.0M",
        "$79.8M"
       ]
      },
      {
       "label": "Jan 24, 2025",
       "cells": [
        "LEFKOFSKY ERIC P Chief Executive Officer",
        "Sell",
        "1.2M",
        "$62.0M"
       ]
      },
      {
       "label": "Mar 6, 2025",
       "cells": [
        "LEFKOFSKY ERIC P Chief Executive Officer",
        "Sell",
        "812.3K",
        "$41.1M"
       ]
      },
      {
       "label": "Jun 18, 2025",
       "cells": [
        "LEFKOFSKY ERIC PAUL Chief Executive Officer",
        "Sell",
        "500.0K",
        "$34.9M"
       ]
      },
      {
       "label": "Jan 17, 2025",
       "cells": [
        "KEYWELL BRADLEY A Former",
        "Sell",
        "946.1K",
        "$33.1M"
       ]
      },
      {
       "label": "Jan 17, 2025",
       "cells": [
        "KEYWELL BRADLEY A Beneficial Owner of more than 10% of a Class of Security",
        "Sell",
        "946.1K",
        "$33.1M"
       ]
      },
      {
       "label": "Oct 28, 2025",
       "cells": [
        "LEFKOFSKY ERIC PAUL Chief Executive Officer",
        "Sell",
        "332.5K",
        "$29.6M"
       ]
      },
      {
       "label": "Sep 25, 2025",
       "cells": [
        "LEFKOFSKY ERIC PAUL Chief Executive Officer",
        "Sell",
        "332.5K",
        "$25.5M"
       ]
      },
      {
       "label": "Aug 27, 2025",
       "cells": [
        "LEFKOFSKY ERIC PAUL Chief Executive Officer",
        "Sell",
        "332.5K",
        "$24.6M"
       ]
      }
     ]
    }
   ],
   "links": [
    {
     "text": "SEC Form 4",
     "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=Tempus+AI+Inc&type=4&dateb=&owner=include&count=40&search_text=&action=getcompany"
    }
   ]
  },
  {
   "id": "faq",
   "title": "Frequently Asked Questions"
  }
 ],
 "faq": [
  {
   "question": "Is Tempus AI Inc (TEM) stock a buy right now?",
   "answer": "Tempus AI Inc (TEM) is currently rated as a Hold, with a consensus score of 59. While revenue growth is strong and analysts have a median price target of $70, significant insider selling and a high Price-to-Sales ratio present considerable risks."
  },
  {
   "question": "What is TEM's stock price forecast for 2030?",
   "answer": "Based on Monte Carlo simulations, Tempus AI Inc (TEM) has a base case price projection of $106.50 for 2030, with a downside scenario of $29.56 and an upside scenario of $383.65. These are statistical outcomes, not guarantees."
  },
  {
   "question": "How does Tempus AI Inc (TEM) compare to its sector averages?",
   "answer": "Tempus AI Inc (TEM) shows stronger revenue growth (21.6%) than the sector median (8.1%). However, its Price-to-Sales ratio (7.44) is higher than the sector median (3.70), and its Return on Equity (-67.44%) is significantly weaker than the sector median (6.9%)."
  },
  {
   "question": "What are the main risks facing Tempus AI Inc (TEM)?",
   "answer": "The primary risks include substantial insider selling totaling over $320 million, a high Price-to-Sales ratio of 7.44 compared to sector peers, and the company's current lack of profitability with negative margins."
  },
  {
   "question": "How has Tempus AI Inc (TEM) performed in recent earnings reports?",
   "answer": "Tempus AI Inc (TEM) has consistently beaten EPS loss estimates in recent quarters, such as reporting -0.04 against an estimate of -0.15 for the quarter ending June 2026. Despite these beats, the stock has seen negative price reactions in some instances."
  },
  {
   "question": "What is the Wall Street consensus for Tempus AI Inc (TEM)?",
   "answer": "The Wall Street consensus for Tempus AI Inc (TEM) is a Hold, with a score of 59 out of 100. This is based on 19 analysts, with 2 Strong Buys, 8 Buys, 8 Holds, and 1 Sell rating."
  },
  {
   "question": "What are the key catalysts or events to watch for Tempus AI Inc (TEM)?",
   "answer": "Investors should monitor future earnings reports for continued EPS beats and progress towards profitability. Additionally, any shifts in insider transaction activity or new strategic partnerships could serve as significant catalysts."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "RMD",
    "name": "ResMed Inc. NYSE",
    "price": "$229.44",
    "change": "+2.89%",
    "url": "https://clearank.com/stock/rmd-stock-analysis/"
   },
   {
    "ticker": "CRNX",
    "name": "Crinetics Pharmaceuticals, Inc. NASDAQ",
    "price": "$84.95",
    "change": "+0.00%",
    "url": "https://clearank.com/stock/crinetics-pharmaceuticals-crnx/"
   },
   {
    "ticker": "CNC",
    "name": "Centene Corp. NYSE",
    "price": "$67.66",
    "change": "-2.52%",
    "url": "https://clearank.com/stock/centene-cnc/"
   },
   {
    "ticker": "ILMN",
    "name": "Illumina Inc. NASDAQ",
    "price": "$222.36",
    "change": "+6.80%",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "RXRX",
    "name": "Recursion Pharmaceuticals, Inc. NASDAQ",
    "price": "$3.24",
    "change": "-4.99%",
    "url": "https://clearank.com/stock/rxrx-stock-analysis/"
   },
   {
    "ticker": "MDT",
    "name": "Medtronic NYSE",
    "price": "$93.75",
    "change": "-0.05%",
    "url": "https://clearank.com/stock/medtronic-mdt/"
   },
   {
    "ticker": "MRK",
    "name": "Merck & Co., Inc. NYSE",
    "price": "$143.17",
    "change": "-1.16%",
    "url": "https://clearank.com/stock/merck-mrk/"
   },
   {
    "ticker": "QDEL",
    "name": "QuidelOrtho Corporation NASDAQ",
    "price": "$11.12",
    "change": "-5.60%",
    "url": "https://clearank.com/stock/quidelortho-qdel/"
   }
  ],
  "comparisons": [
   {
    "ticker": "UEC vs CCJ Comparison",
    "name": "",
    "url": "https://clearank.com/compare/uec-vs-ccj/"
   },
   {
    "ticker": "SCHD vs JEPI Comparison",
    "name": "",
    "url": "https://clearank.com/compare/schd-vs-jepi/"
   },
   {
    "ticker": "ENPH vs FSLR Comparison",
    "name": "",
    "url": "https://clearank.com/compare/enph-vs-fslr/"
   }
  ],
  "sectorHub": {
   "text": "Browse all Healthcare →",
   "url": "https://clearank.com/sector/healthcare/"
  },
  "Newly Tracked": [
   {
    "ticker": "ILMN",
    "text": "Illumina Inc.",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "GWRE",
    "text": "Guidewire Software Inc.",
    "url": "https://clearank.com/stock/gwre-stock-analysis/"
   },
   {
    "ticker": "ROST",
    "text": "Ross Stores Inc.",
    "url": "https://clearank.com/stock/rost-stock-analysis/"
   },
   {
    "ticker": "LUGDF",
    "text": "Lundin Gold Inc",
    "url": "https://clearank.com/stock/lugdf-stock-analysis/"
   },
   {
    "ticker": "KEYS",
    "text": "Keysight Technologies, Inc.",
    "url": "https://clearank.com/stock/keys-stock-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "SBET",
    "text": "↓ 8.96%",
    "url": "https://clearank.com/stock/sharplink-sbet/"
   },
   {
    "ticker": "CAVA",
    "text": "↓ 8.93%",
    "url": "https://clearank.com/stock/cava-group-cava/"
   },
   {
    "ticker": "ARB/USD",
    "text": "↑ 19.42%",
    "url": "https://clearank.com/crypto/arbitrum-arb-usd/"
   },
   {
    "ticker": "INJ/USD",
    "text": "↓ 11.80%",
    "url": "https://clearank.com/crypto/injective-inj/"
   },
   {
    "ticker": "CRV/USD",
    "text": "↓ 11.53%",
    "url": "https://clearank.com/crypto/crv-usd-crypto-analysis/"
   }
  ],
  "Also in Healthcare": [
   {
    "ticker": "RXRX",
    "text": "Recursion",
    "url": "https://clearank.com/stock/rxrx-stock-analysis/"
   },
   {
    "ticker": "SYK",
    "text": "Stryker Corporation",
    "url": "https://clearank.com/stock/stryker-syk/"
   },
   {
    "ticker": "TLRY",
    "text": "Tilray Brands, Inc.",
    "url": "https://clearank.com/stock/tilray-brands-tlry/"
   },
   {
    "ticker": "TMO",
    "text": "Thermo Fisher",
    "url": "https://clearank.com/stock/tmo-stock-analysis/"
   },
   {
    "ticker": "VEEV",
    "text": "Veeva Systems Inc.",
    "url": "https://clearank.com/stock/veev-stock-analysis/"
   }
  ],
  "news": [
   {
    "title": "Tempus AI (TEM): The NVIDIA of Precision Medicine",
    "date": "Nov 25, 2025",
    "url": "/news/tempus-ai-tem-forecast/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "alternateName": "CleaRank Financial AI",
     "url": "https://clearank.com",
     "description": "CleaRank is where retail traders research a trade and practice it before risking money. Its research arm, CleaRank Financial AI, publishes daily analysis, trade plans and 10-year projections for more than 1,000 stocks, ETFs, cryptocurrencies, forex pairs and commodities; each page is built from licensed market data, carries the date it was last updated and is reviewed under CleaRank's published editorial code. The CLEAR™ Score rates online brokers and prop firms on regulation, fees, platform reliability and verified trader experience. The research is free; CleaRank is paid for by subscriptions to its trading workbench (Pro $29 a month, Ultra $59 a month), which combines a live trading simulator, a trade journal that imports from broker history, an AI coach grounded in the trader's own trades, a portfolio generator, visualizer and backtester, a prop-firm challenge auditor and 22 trading calculators and scanners. Some free content contains partner links, which are disclosed and do not affect ratings.",
     "slogan": "Clear data. Honest analysis.",
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "image": {
      "@id": "https://clearank.com/#logo"
     },
     "sameAs": [
      "https://x.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank",
      "https://t.me/clearank"
     ],
     "email": "info@clearank.com",
     "contactPoint": [
      {
       "@type": "ContactPoint",
       "contactType": "customer support",
       "email": "info@clearank.com",
       "url": "https://clearank.com/contact/",
       "availableLanguage": "en"
      }
     ],
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     },
     "knowsAbout": [
      "stock analysis",
      "ETF analysis",
      "cryptocurrency analysis",
      "forex trading",
      "trading simulation",
      "trade journaling",
      "position sizing",
      "risk management",
      "prop firm challenges",
      "online broker regulation"
     ],
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "ethicsPolicy": "https://clearank.com/editorial-code/",
     "ownershipFundingInfo": "https://clearank.com/about-us/",
     "owns": {
      "@id": "https://clearank.com/#app"
     },
     "founder": {
      "@id": "https://clearank.com/writer/shaundavidb/#person"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/wp-content/uploads/2026/07/tem.png",
     "url": "https://clearank.com/wp-content/uploads/2026/07/tem.png",
     "width": "1280",
     "height": "720",
     "caption": "Tempus AI Inc (TEM) stock price analysis chart for July 2026",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/tempus-ai-tem/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/stock/tempus-ai-tem/",
        "name": "Tempus AI Inc (TEM) Stock Price Analysis"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/tempus-ai-tem/#webpage",
     "url": "https://clearank.com/stock/tempus-ai-tem/",
     "name": "Tempus AI (TEM) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-07-01T09:38:46+00:00",
     "dateModified": "2026-09-16T06:45:52+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/wp-content/uploads/2026/07/tem.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/tempus-ai-tem/#breadcrumb"
     },
     "reviewedBy": {
      "@id": "https://clearank.com/writer/shaundavidb/#person"
     }
    },
    {
     "@type": "Person",
     "@id": "https://clearank.com/writer/shaundavidb/#person",
     "name": "Shaun David",
     "jobTitle": "Co-Founder",
     "url": "https://clearank.com/writer/shaundavidb/",
     "image": "https://clearank.com/media/uploads/2025/01/Shaun-David-Author-Image-.jpeg",
     "sameAs": [
      "https://www.linkedin.com/in/shaun-david-697b5817a/"
     ],
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     }
    },
    {
     "@type": "Article",
     "@id": "https://clearank.com/stock/tempus-ai-tem/#richSnippet",
     "headline": "Tempus AI (TEM) Stock Forecast & Price Target (2026)",
     "name": "Tempus AI (TEM) Stock Forecast & Price Target (2026)",
     "description": "Tempus AI Inc (TEM) stock: Healthcare, Health Information Services. $12.4B market cap. AI rating, technicals, 2030 forecast and trade plans.",
     "datePublished": "2026-07-01T09:38:46+00:00",
     "dateModified": "2026-09-16T06:45:52+00:00",
     "author": {
      "@id": "https://clearank.com/#organization"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "about": {
      "@type": "Corporation",
      "name": "Tempus AI Inc",
      "identifier": [
       {
        "@type": "PropertyValue",
        "propertyID": "tickerSymbol",
        "value": "TEM"
       },
       {
        "@type": "PropertyValue",
        "propertyID": "exchange",
        "value": "NASDAQ"
       }
      ],
      "description": "Tempus AI Inc Class A Common Stock is the equity of Tempus AI, a healthcare technology company focused on applying artificial intelligence and machine learning to precision medicine. The company develops AI-enabled solutions that help physicians use clinical and molecular data to support more person",
      "tickerSymbol": "TEM",
      "sameAs": "https://www.tempus.com"
     },
     "isPartOf": {
      "@id": "https://clearank.com/stock/tempus-ai-tem/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/wp-content/uploads/2026/07/tem.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/tempus-ai-tem/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "Is Tempus AI Inc (TEM) stock a buy right now?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Tempus AI Inc (TEM) is currently rated as a Hold, with a consensus score of 59. While revenue growth is strong and analysts have a median price target of $70, significant insider selling and a high Price-to-Sales ratio present considerable risks."
     }
    },
    {
     "@type": "Question",
     "name": "What is TEM's stock price forecast for 2030?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Based on Monte Carlo simulations, Tempus AI Inc (TEM) has a base case price projection of $106.50 for 2030, with a downside scenario of $29.56 and an upside scenario of $383.65. These are statistical outcomes, not guarantees."
     }
    },
    {
     "@type": "Question",
     "name": "How does Tempus AI Inc (TEM) compare to its sector averages?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Tempus AI Inc (TEM) shows stronger revenue growth (21.6%) than the sector median (8.1%). However, its Price-to-Sales ratio (7.44) is higher than the sector median (3.70), and its Return on Equity (-67.44%) is significantly weaker than the sector median (6.9%)."
     }
    },
    {
     "@type": "Question",
     "name": "What are the main risks facing Tempus AI Inc (TEM)?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The primary risks include substantial insider selling totaling over $320 million, a high Price-to-Sales ratio of 7.44 compared to sector peers, and the company's current lack of profitability with negative margins."
     }
    },
    {
     "@type": "Question",
     "name": "How has Tempus AI Inc (TEM) performed in recent earnings reports?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Tempus AI Inc (TEM) has consistently beaten EPS loss estimates in recent quarters, such as reporting -0.04 against an estimate of -0.15 for the quarter ending June 2026. Despite these beats, the stock has seen negative price reactions in some instances."
     }
    },
    {
     "@type": "Question",
     "name": "What is the Wall Street consensus for Tempus AI Inc (TEM)?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The Wall Street consensus for Tempus AI Inc (TEM) is a Hold, with a score of 59 out of 100. This is based on 19 analysts, with 2 Strong Buys, 8 Buys, 8 Holds, and 1 Sell rating."
     }
    },
    {
     "@type": "Question",
     "name": "What are the key catalysts or events to watch for Tempus AI Inc (TEM)?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Investors should monitor future earnings reports for continued EPS beats and progress towards profitability. Additionally, any shifts in insider transaction activity or new strategic partnerships could serve as significant catalysts."
     }
    }
   ]
  }
 ]
}